The study's long-term goal is to identify and define pathways that lead from variations in the DNA sequence of the genome to the irreversible vision loss of glaucoma, said John Fingert, M.D., the study's principal investigator and an assistant professor of ophthalmology and visual sciences in the UI Roy J. and Lucille A. Carver College of Medicine and an ophthalmologist with UI Hospitals and Clinics.